Innovative Drug Discovery and Development

Home Home Research Consortia Innovative Drug Discovery and Development

Gulf Coast Consortium for Innovative Drug Discovery and Development

Formerly the John S. Dunn Gulf Coast Consortium for Chemical Genomics (GCC CG) which was formed in 2003, the Consortium for Innovative Drug Discovery and Development (GCC IDDD) is a research consortium focused on providing support for Houston/Galveston scientists in advancing their therapeutics discoveries through development to the clinic. IDDD support includes collaborative networking and joint funding opportunities, shared core resources, and educational programs.

New! The Cancer Therapeutics Training Program (CTTP)

The Cancer Therapeutics Training Program (CTTP) is a multi-institutional post-doctoral training program designed to prepare post-doctoral trainees for future careers in academic and/or commercial cancer therapeutics research and development (R&D). The goal of the program is to recruit and train scientists equipped with the essential skills and knowledge necessary to translate basic cancer research discoveries into commercially viable cancer therapeutics. For more information, visit the CTTP Website.

News

Upcoming Events

IDDD Roundtable Workshop: Advanced Imaging in Drug Discovery

Presented by the GCC Innovative Drug Discovery and Development Consortia, the GCC Cancer Therapeutics Training Program (CTTP), and the GCC Innovative Drug Discovery and Development Scholars Program, we invite you to join […]

Find out more